The Price Insulin Truly Has On American Lives
Faculty Mentor
Rosalee Allen
Document Type
Poster
Start Date
10-5-2023 9:00 AM
End Date
10-5-2023 10:45 AM
Location
PUB NCR
Department
Health Services Administration
Abstract
Chronic illnesses are a global issue and therefore are a more researched topic around the world, especially if they are common among populations. Most of these illnesses require medications to maintain a good quality of life or even in some cases just to survive. In this study, we will be looking at those who meet the expectations of the latter requirement for prescriptions, more specifically, the illness Diabetes Mellitus and how the prices of insulin in the United States of America are forcing Americans to fast their rations of insulin that are covered by insurance, thus risking their own lives with complications like Acute Myocardial Infarction. We will focus on the rates of ICU admissions in the USA for the primary diagnosis being AMI and a secondary diagnosis for DM. We will compare that to countries who are honest about their insulin prices and are labeled as more “healthcare affordable”, along with providing research around the world of the complications and dangers of fasting insulin doses. The price of Insulin should not come at the cost of American lives, or even take away the quality of those lives when we have medications that can easily improve them. Our country willingly lets people die from preventable diseases just so pharmaceutical companies can be greedy on a population that has no other choice. There is enough evidence to prove that rationing one's insulin while they have diabetes mellitus makes them much more likely to be admitted to the ICU fighting for their life with an acute myocardial infarction.
Recommended Citation
Springer, Elena and Malcom, Cora, "The Price Insulin Truly Has On American Lives" (2023). 2023 Symposium. 5.
https://dc.ewu.edu/srcw_2023/res_2023/p1_2023/5
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
The Price Insulin Truly Has On American Lives
PUB NCR
Chronic illnesses are a global issue and therefore are a more researched topic around the world, especially if they are common among populations. Most of these illnesses require medications to maintain a good quality of life or even in some cases just to survive. In this study, we will be looking at those who meet the expectations of the latter requirement for prescriptions, more specifically, the illness Diabetes Mellitus and how the prices of insulin in the United States of America are forcing Americans to fast their rations of insulin that are covered by insurance, thus risking their own lives with complications like Acute Myocardial Infarction. We will focus on the rates of ICU admissions in the USA for the primary diagnosis being AMI and a secondary diagnosis for DM. We will compare that to countries who are honest about their insulin prices and are labeled as more “healthcare affordable”, along with providing research around the world of the complications and dangers of fasting insulin doses. The price of Insulin should not come at the cost of American lives, or even take away the quality of those lives when we have medications that can easily improve them. Our country willingly lets people die from preventable diseases just so pharmaceutical companies can be greedy on a population that has no other choice. There is enough evidence to prove that rationing one's insulin while they have diabetes mellitus makes them much more likely to be admitted to the ICU fighting for their life with an acute myocardial infarction.
